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Abstract 
 
Population size is crucial when estimating population-normalized drug consumption (PNDC) from 
wastewater-based drug epidemiology (WBDE). Three conceptually different population estimates 
can be used: de jure (common census, residence), de facto (all persons within a sewer catchment), 
and chemical loads (contributors to the sampled wastewater). De factoand chemical loads will be 
the same where all households contribute to a central sewer system without wastewater loss. This 
study explored the feasibility of determining a de factopopulation and its effect on estimating PNDC 
in an urban community over an extended period. Drugs and other chemicals were analyzed in 311 
daily composite wastewater samples. The daily estimated de facto population (using chemical loads) 
was on average 32% higher than the de jure population. Consequently, using the latter would 
systemically overestimate PNDC by 22%. However, the relative day-to-day pattern of drug 
consumption was similar regardless of the type of normalization as daily illicit drug loads appeared 
to vary substantially more than the population. Using chemical loads population, we objectively 
quantified the total methodological uncertainty of PNDC and reduced it by a factor of 2. Our study 
illustrated the potential benefits of using chemical loads population for obtaining more robust PNDC 
data in WBDE. 
 
  
1 Introduction 
 
Measuring drug residues in raw sewage–subsequently referred to as wastewater-based drug 
epidemiology (WBDE)—has become an important tool to estimate illicit drug use worldwide. The 
final estimate is typically presented on a basis of per capita consumption (i.e., consumed mass of a 
drug per capita per day). The back-estimation methodology of WBDE relies on a number of 
parameters, including concentrations of drug residues, wastewater volumes, excretion fractions, and 
population size.(1) There is uncertainty in each of these parameters. One key component concerns 
the number of people in a catchment, which can substantially affect the accuracy of the final 
estimate and comparisons of data across different communities.(1, 2) The variability and accuracy of 
this parameter cannot be easily estimated. 
In most WBDE studies, the population parameter has been obtained either from the design capacity 
of wastewater treatment plants (WWTPs) or the most recently available census data.(3)Design 
capacity usually refers to population equivalents including industrial pollutant loads and also refers 
to a certain (long-term) planning horizon. For these two reasons, usually less people contribute to 
the wastewater than indicated by design capacity. In exceptional circumstances, WWTPs may also 
operate above design capacity to receive wastewater from more people than expected. However, 
this is difficult to assess and quantify objectively. Census data, taken on a specific day, provide only a 
single estimate of a population size; typically, it refers to a de jure population, which is counted 
according to home address, but does not provide important information on whether people are 
actually within the WWTP catchment under investigation or elsewhere on a specific day. Relying on 
such a fixed population size may not be practical to WBDE.(1) 
Researchers have recommended that attempts should be made to estimate the number of people 
effectively contributing to a wastewater sample; e.g., see refs 1, 3, and 4. A few indicators have been 
proposed to estimate de facto populations by means of chemical loadsmeasured in wastewater. 
Theoretically, if all households in the catchment of a WWTP are connected to a central sewer 
system, and assuming that no wastewater losses occur—e.g., leaky sewers, wastewater bypassing 
the WWTP during rainy periods, or abnormal operational situations—the population estimated from 
chemical loads in wastewater is a fair approximation of de facto population. Therefore, de 
facto subsequently refers to both de facto population and population estimated from chemical 
loads.(4) 
For practical applicability in WBDE it appears important that (i) selected chemicals are human-
specific; (ii) the method is applied over an extended period of consecutive days (to reveal day-to-day 
variation); (iii) methodological uncertainties can be quantified objectively; and (iv) the relevance of 
the parameter populations size is determined in the context of the overall methodological 
uncertainty of WBDE. 
Human-specific chemicals were proposed—but not validated—in five studies, namely, creatinine,(5, 
6) coprostanol,(4) cholesterol, cotinine, and a neurotransmitter metabolite, 5-hydroxyindoleacetic 
acid,(7) and commonly prescribed pharmaceuticals and artificial sweeteners.(8) Only two studies 
were found in which the measurement was over an extended period: one covered 235 days in a 1 
year period using hydrochemical parameters (nitrogen, phosphorus, biological oxygen demand, and 
chemical oxygen demand), and another one covered 13 days in an 8 month period using 
ammonium;(9, 10) those selected chemicals are not human-exclusive. Only one recent publication 
provides an approach to quantify objectively the methodological uncertainty of the population 
estimates.(11) Lastly, the two studies addressing population size estimation in the context of overall 
uncertainty were review-type reports that did not provide new methods.(2, 12) In summary, to the 
best of our knowledge, no study to date has addressed all four aspects listed previously in a 
comprehensive manner that is pertinent to their applicability in WBDE. Furthermore, most studies 
rely on a day-specific excretion fraction by one person, which does not allow an objective 
quantification of associated uncertainty if these values are either missing or unreliable. 
Recently, a multisubstance model to estimate de facto population was developed and calibrated 
with wastewater samples collected on a census day.(11) Applying this model facilitates the 
examination of the variation in daily de facto populations over time in large catchments and 
consequently its effect on the estimation of population-normalized illicit drug loads in WBDE—
particularly when compared to using a constant population number such as that from census data. 
The aims of our study were to (a) estimate a day-specific de facto population using the recently 
developed model in a large catchment on consecutive days over an extended period, (b) compare 
the estimated de facto populations with the de jure population and the effects of using the different 
population estimates on temporal patterns and levels of illicit drug use, and (c) evaluate whether the 
overall methodological uncertainty of WBDE can be reduced and better quantified using day-specific 
estimated de facto populations. 
 
2 Materials and Methods 
 
2.1Wastewater Sampling 
The sampling was set up at the inlet of a wastewater treatment plant that served a mainly urban 
catchment in South East Queensland (Australia) with a de jure population of 211,340 people and 
a de facto population of 230,117 on census day (Aug. 11, 2011) according to the Australian Bureau of 
Statistics.(13) Samples were collected between June 2011 and June 2012 (n = 311 days; see Table S1 
in the Supporting Information for missing data (n = 33 days) due to logistical or technical reasons). A 
continuous flow-proportional sampling technique was applied to ensure collection of representative 
daily composite samples (from 6 AM to 6 AM the next day).(14, 15)The samples were refrigerated at 
4 °C during collection, acidified on site to pH 2 using 2 M hydrochloric acid, and then frozen until 
analysis. This preservation method has been commonly used and can stabilize the targeted residues 
of illicit drugs in wastewater during storage; e.g., see refs 5 and 16. Data on daily wastewater 
volumes were recorded by the WWTP. 
2.2Analysis of Targeted Compounds 
Samples were analyzed for the targeted illicit drug residues and high-use chemicals using liquid 
chromatography (Shimadzu, Nexera UHPLC system, Kyoto, Japan) coupled with tandem mass 
spectrometry (AB SCIEX QTRAP5500, Ontario, Canada) (LC-MS/MS). The analytical method applied in 
this study has been validated and described previously.(8, 11) Briefly, an electronic robot (Tecan 
Genesis Workstation 200, Australia) was used to transfer filtered samples into a vial which were then 
spiked with mixtures of carbon-labeled and deuterium-labeled chemical standards (Table S2 of 
the Supporting Information) for compensating potential instrumental variability and matrix effects 
during analysis. Separation of the targeted analytes was performed on a C18 LC analytical column 
using gradient mobile phases (Table S2 of the Supporting Information). Together with the calibration 
standards, concentrations of the targeted analytes were measured using mass spectrometry with a 
multireaction monitoring (MRM) scheme. Two MRM transitions were used for identification and 
quantification of each analyte.(8, 11)Concentrations of the targeted analytes have taken the 
recovery of the spiked mass-labeled standards into account (i.e., isotope dilution method). 
In every batch of analysis, Milli-Q water samples (i.e., procedural blanks), duplicate samples, and 
samples spiked with native chemicals were included as quality assurance and control (QA/QC) of the 
analysis. The QA/QC results are summarized in Table S3 of the Supporting Information. Briefly, no 
contamination was found in the blank samples. The difference (coefficient of variance, CV (%)) 
between duplicate samples was on average 4.8–7.9% for the illicit drug residues and 4.2–9.4% for 
the high-use chemicals. Recovery of the native chemicals spiked in the samples was 75–81% for the 
illicit drug residues and 99–113% for the high-use chemicals. Interday variation across 3 days was 
2.3–11% for the illicit drug residues and 4.7–21% for the high-use chemicals. 
2.3Estimating Daily de facto Populations 
Day-specific de facto populations and confidence intervals were estimated with the multisubstance 
model.(11) Details on the calculation (calibration, Bayesian inference, and validation) can be found in 
O’Brien et al.(11) Briefly, we calibrated the model with mass loads of 14 chemicals in the influent of 
10 WWTPs (catchment sizes ranging from approximately 3,500 to 500,000 people) and de 
facto populations, both determined on or around the last Australian census day. It should be noted 
that normally census data refer to de jure populations; however, in Australia, de facto populations 
are also determined on census day.(11) In this study, we only used eight chemicals that can be 
readily measured in the samples without preconcentration, consistent with the measurement of the 
targeted illicit drug residues. These eight high-use chemicals included acesulfame, atenolol, caffeine, 
carbamazepine, codeine, hydrochlorothiazide, naproxen, and salicylic acid. Model calculations 
indicated that the use of eight chemicals provided de facto population estimates consistent with 
using 14 chemicals (Table S4 of the Supporting Information). It should be noted that any variability 
that is unknown or cannot be quantified explicitly was implicitly accounted for when calibrating the 
model with mass loads of the high-use chemicals in wastewater from various catchments and 
accurate population sizes. The uncertainties encompass systematic or random effects due to, e.g., 
disposals of unused chemicals, unknown absolute excretion rates, day-to-day variations of actual 
consumption, and transformations of chemicals in sewer systems, sampling, and storage (see 
O’Brien et al. for more explanation).(11) It is a fair assumption that the system under investigation 
(e.g., catchment and sewers), and the relevant processes (e.g., average consumption habits, 
pharmacokinetics, and transformation in sewers) did not change substantially between the census 
day and our monitoring period. 
2.4Population-Normalized Drug Consumption 
The back-estimation method follows the previously proposed equation (see Supporting 
Information).(1) Briefly, the estimation involves three main steps: (a) the mass loads (mg/day) of 
drug residues are obtained by multiplying concentrations (μg/L) with total wastewater flow 
(ML/day); (b) the estimated mass loads are then extrapolated to the consumed amount with a 
correction factor taking the average excretion rate and the ratio of molecular weight between the 
parent drug to its metabolite into account (Table S5 of the Supporting Information); and (c) the 
consumed amount is normalized to a population size to result in the collective consumption of the 
population ((mg/day)/(1000 people)). We chose, when analytically possible, two drug residues (i.e., 
dual tracers, the unchanged parent drug and metabolite) to back-estimate consumption of the 
parent drug (Table S3 of the Supporting Information): cocaine and benzoylecgonine, respectively, for 
estimation of cocaine; methamphetamine and amphetamine, respectively, for estimation of 
methamphetamine (as illicit amphetamine use is rare in Australia);(17) and only MDMA (3,4-
(methylenedioxy)methamphetamine) itself for estimation of MDMA. These targeted residues have 
been demonstrated to be adequate for back-estimating consumption of the corresponding parent 
drug; see, e.g., refs 1, 3, and 18−20. Consistent patterns and consumption rates obtained from the 
two residues allow verification of the reliability of the estimate of the parent drug.(8) 
2.5Uncertainty Analysis 
Previous studies have revealed the uncertainty components associated with the back-estimation 
methodology of WBDE.(-2, 8) Five components were considered for contribution to the overall 
uncertainty (Utot) for the final estimate of population-normalized drug consumption (PNDC; 
(mg/day)/(1000 people)); we refer to the Utot(de jure) as the total uncertainty of the de jure-PNDC 
and Utot(de facto) as the total uncertainty of the de facto-PNDC. These encompass uncertainties 
related to sampling (US), chemical analysis (UC), flow measurements (UF), excretion rates (UE), and 
population size (UP). The magnitude of each uncertainty component is presented as relative 
standard deviations (RSD, %)(8) as determined from modeling results forUS and UP, interday 
variability of instrumental analysis for UC, literature data for UE, and estimates from WWTP 
operators for UF (Table 1). These uncertainty components are independent from each other, 
because they arise from individual aspects of studies and the methods of calculating them. As the 
primary metabolite chosen for back-estimating consumption of the three illicit drugs is relatively 
stable under typical sewer conditions,(21) we therefore consider the uncertainty of in-sewer 
chemical biodegradation as negligible. This study used Monte Carlo simulation to estimate Utot as 
described previously.(22, 23) Linear error propagation as suggested earlier, see, e.g., ref 8, only 
provides a good approximation of Utot ifUP is small and also other uncertainty components do not 
exceed a certain value. Otherwise the linear error propagation tends to systematically 
underestimate Utot. 
2.6 Statistics 
Nonparametric Mann–Whitney tests (unpaired) were used to examine significant differences 
between weekdays and weekends for the estimated de facto populations and for illicit drug 
consumption. Nonparametric Wilcoxon tests (paired) were used to assess significant differences 
between population-normalized consumption based on de jure and de facto populations. The 
statistics were performed using GraphPad Prism (version 6.00, GraphPad Software Inc.). 
 
3 Results and Discussion 
 
3.1Estimated Day-Specific de facto Populations 
The de facto population for individual days was estimated in a range between 96,400 and 466,000 
(minimum–maximum; 90% interquantile, 96,400–304,000 (25% of all days were outside this range)), 
with an average of 280,000 persons and a variation (CV) of 15.6% throughout 311 monitoring days 
(Figure 1A). The variation of our data is similar to that reported in Brussels over 235 days (CV, 18%; 
90% interquantile, 495,000–1,040,000 (25% of all days outside this range)).(9) We observed a mild 
seasonal variation in the estimated de facto population in the catchment: it gradually increased from 
approximately 264,000 to 284,000 persons (monthly average; Table S6 of the Supporting 
Information) between July and September, remained at about 300,000 persons from October to 
December 2011, was recorded as the highest estimate of 310,000 persons in January 2012, and then 
slowly decreased from 294,000 persons in February to 243,000 persons in June 2012. The yearly 
average de facto population on the weekends (∼280,000 persons) was similar to that during the 
weekdays (∼278,000 persons) over the study period, as were most of the months (Figure 1A). The 
variation (CV) of the estimated de factopopulation among individual week days was relatively lower 
for Monday (13%), Friday (14%), and Sunday (13%) but slightly higher for Saturday (18%) and from 
Tuesday to Thursday (16–17%). There was also a significant difference in the estimated de 
facto populations between Sundays and Wednesdays–Saturdays (p = 0.005–0.03) and between 
Mondays and Tuesdays–Saturdays (p < 0.0001–0.005). 
3.2 Comparison between Two Different Population Estimates 
The estimated de facto population (∼280,000 people) is on average about 32% higher than thede 
jure population (i.e., ∼211,000 people on the census day) (Figure 1B). For almost all days, the 
estimated de facto population was higher than the de jure population (Figure 1A). The difference 
ranged from +2.1 to +120% (Figure 1B). On only 17 days was the estimated de factopopulation lower 
than the de jure population, ranging from −2.8 to −54% (Figure 1B). The overall differences between 
the estimated de facto population and the de jure population appear reasonable because the 
studied catchment is one of the most urbanised areas in South East Queensland and it is a popular 
destination for domestic and international visitors with many resorts, music festivals, theme parks, 
and tourist attractions that operate throughout the year. High commuting flow is thus common in 
the catchment area. 
While the difference between the estimated de facto population and the de jure population is in a 
range of 22–44% (25–75 percentile) for half of the monitoring days (Figure S2 of the Supporting 
Information), there were some days on which there was a substantial increase or decrease in the 
estimated de facto population compared to the de jure population (Figure 1B). For example, an 
elevated de facto population was estimated on Nov. 28, 2011 (+101%, Figure 1B), Jan. 26, 2012 
(+120%, Figure 1B) and Jan. 30, 2012 (+94%, Figure 1B). We noticed a coincidence between a high 
rainfall level recorded from Jan. 23, 2012 to Jan. 30, 2012 (peak rainfall on Jan. 25, 2012 with ∼230 
mm)(24) and an increase in the de facto population on Jan. 26, 2012 and Jan. 30, 2012. However, it 
should be noted that the de facto population, estimated based on the daily mass loads of the high-
use chemicals, cannot be driven by the increase in wastewater volumes and is independent of the 
dilution factor, as long as the lowered concentrations of the chemicals are still above the 
quantification limits. This can be seen from the data, for example, on Mar. 4, 2012 and Mar. 29, 
2012, when increased wastewater volumes due to rainfall around these days (Figure S3A) did not 
result in an increase in estimated de facto population (Figure1A,B). Higher de facto population 
estimates may reflect either an increase in per capita consumption of the high-use chemicals or 
more people being present who consume the usual per capita amount of the chemicals. The 
observed elevated de facto population appears reasonable because (a) every November is a special 
period when young teenagers gather in this urban catchment to celebrate their completion of 
secondary school and (b) the 26th of January is the Australia Day public holiday, so the catchment 
attracts a lot of people for holidays and celebration activities. On some of the monitoring days, the 
estimated de facto population was substantially lower than the de jure population (Figure 1A), for 
example, the data on Jan. 24, 2012 (−48%, Figure 1B) and Apr. 28, 2012 (−54%, Figure 1B). Heavy 
rainfall events were recorded in the catchment around those 2 days. This may have led to a diversion 
of wastewater (combined sewer overflows), resulting in substantially decreased mass loads of high-
use chemicals entering the WWTP. However, PNDC is still thought to be unbiased as explained at the 
end of the next section. 
3.3 Effects on PNDC Using Different Population Estimates 
The deviation between the de facto-PNDC and the de jure-PNDC is calculated as the following:
 
This gives negative deviations (−2 to −54.6%) for most of the monitoring days (Figure 1C) since the 
PNDC is reduced when the drug load is normalized to the estimated de facto population which is 
greater than the de jure population. By contrast, the deviation becomes positive (+2.9 to +119%) 
when the drug load is normalized to an estimated de facto population that is smaller than the de 
jure population (Figure 1C). There were significant differences (p < 10–4) between the de 
facto population normalized and de jure population normalized consumption of the three illicit 
drugs. Over the monitoring period, the PNDC based on the estimated de facto populations was 
systematically lower by 22% (Figure 1C) because the average de facto population was 32% higher 
than the de jure population (Figure 1B). This indicates that the model of estimating the de 
facto populations allows for the assessment of how systematic differences in the population drug 
consumption are related to changes in the number of people who contributed in the sampled 
wastewaters in the studied catchment. 
While there were absolute differences in the PNDC estimated using the two different population 
estimates, the relative day-to-day pattern of consumption for the three illicit drugs did not 
significantly change over the monitoring period (Figure S4 of the Supporting Information). The 
variation of PNDC was very similar, regardless of whether one used the estimated de facto or de 
jure population (de facto/de jure: for cocaine, 55%/59%; for methamphetamine, 38%/37%; for 
MDMA, 132%/138%) (CV, in Table S7 of the Supporting Information). The same was true for 
variations between weekdays and weekends over the year (Table S7 of the Supporting Information). 
Our data are in line with those of a recent study(23) which summarized and reported that only a 
small variation in a PNDC was observed between estimates made using de jure and de 
facto populations. For example, in Brussels, using hydrochemical parameters for de 
facto populations and census for de jure populations (census = 1.1 million people), the CVs for PNDC 
differed only slightly (de facto/de jure: for cocaine, 33%/31%; for methamphetamine, 40%/41%; for 
MDMA, 180%/186%).(9) Our data also follow the result of another recent study which revealed 
consistent patterns of per capita illicit drug use between using census data (de jure 220,000 persons) 
and estimated population numbers using ammonium ions in the urban area of Lausanne, 
Switzerland.(10) These coherent findings among international studies in large catchments indicate 
that the consumed mass of illicit drugs varies more substantially than the population, and 
consequently, relative temporal changes of population drug consumption usually persist irrespective 
of the type of population estimates used for normalization. This may not be the case for small 
catchments and days with special events. 
Despite the absence of large variations in the overall day-to-day patterns, we observed 19 days with 
substantially higher or lower differences between the population’s drug consumption using the two 
different population estimates (Figure S5 of the Supporting Information). Those exceptional days 
indicate that a day-specific de facto population estimate is essential when estimating a PNDC on a 
single day. Our data suggest that it is hard to predict when substantial variations in de 
facto populations happen since those exceptional days were randomly detected and not simply 
related to specific events in the catchment. The deviations in population drug consumption on these 
19 days may have been due to (a) the “normal number” of people increasing or decreasing their 
overall consumption of the eight high-use chemicals, (b) a substantial increase or a decrease in the 
number of people consuming the “average per capita amount” of the high-use chemicals, or (c) 
unusual operational conditions in the sewer network affecting influent loads in the WWTP. 
Unfortunately, it is not possible to differentiate reasons (a) and (b). However, the values observed 
outside the “normal range of de facto population” indicate that the results of these few days should 
be interpreted cautiously. When using the de jure population, such “caution indicators” are missing. 
An example for reason (c) with “unusual operational conditions” was observed by van Nuijs et 
al.:(9) a de facto population which was less than 10% of the “normal” de facto population was 
estimated because an unreported amount of wastewater did not enter the influent of the WWTP 
where samples were taken. This does not imply that only 10% of the population were in the 
catchment but simply that only 10% of the normal wastewater volume was sampled and used to 
calculate a de facto population. Since the illicit drug loads were also quantified for 10% of the 
wastewater only, the PNDC was not affected. However, if the de jure population had been used, a 
substantial underestimation during the days with unusual operational conditions would have 
resulted; unless one had corrected for the missing wastewater volume, assuming that the 
nonsampled wastewater volumes showed similar concentrations (for both illicit drugs and 
substances to estimate de facto population). In a similar way, faulty flow measurements do not 
affect PNDC when the de facto population is estimated from chemical loads based on the same 
sample and wastewater volumes as illicit drug residues.(8) 
3.4 Temporal Variations 
3.4.1 Cocaine 
Both cocaine and its major urinary metabolite, benzoylecgonine, were measured in all samples and 
used to back-estimate cocaine consumption in the catchment. The yearly average consumption (25–
75 percentile; median) of cocaine was estimated at 264 (mg/day)/(1000 people) (162–315; 230) 
using cocaine itself and 193 (mg/day)/(1000 people) (108–249; 167) using benzoylecgonine. This is 
equal to, on average, approximately two doses in a day among 1000 people, assuming that the 
reference dose of cocaine is 100 mg.(25) Benzoylecgonine has been recommended as the key 
biomarker for back-estimating cocaine consumption because it is exclusively excreted by humans 
and more persistent in wastewater than cocaine.(16, 21, 26, 27) We thus used benzoylecgonine to 
assess the temporal pattern of cocaine consumption in the studied catchment. The overall variation 
of cocaine consumption in this study (55%, Table S7 of the Supporting Information) was about twice 
that reported in Brussels.(9) Cocaine consumption showed a gradual increasing pattern over the 
monitoring period (Figure 2A, Table S6 of the Supporting Information). Epidemiological indicators of 
cocaine use during this period are scant but generally suggest that there was limited use and stable 
markets since there was little change in hospital admissions, information calls, or self-reported 
substance use (among injecting drug and club drug consumers) in surveillance studies.(28-
31) However, analyses of the small number of cocaine seizures suggested that purity increased 
during April–June 2012 compared with previous months in this period.(17) 
The weekly pattern of cocaine consumption was consistent across the time period (Figure 2A). The 
average consumption of cocaine on the weekends (299 (mg/day)/(1000 people)) was approximately 
two times higher than that during the weekdays (149 (mg/day)/(1000 people)) (p< 10–4). This 
implies that, on the weekends, there was either a larger amount of cocaine consumed by the same 
number of regular users and/or an increase in the number of consumers who used a similar 
amount/dose within the catchment. Drug purity was irrelevant to the weekly pattern because it is 
highly unlikely that there would be marked variations in drug purity within the week and the weekly 
pattern is clear regardless of the general level of consumption. Given the urban location of the 
studied site, there were a number of specific events, such as car races, sport competitions, music 
concerts/festivals and New Year celebrations, during the monitoring period. Elevated consumption 
of cocaine coincided with some of the major events in the catchment (Figure 2A). The effect of the 
major events on cocaine consumption was more pronounced than the weekend effect; for example, 
the level of cocaine use on the second-last weekend of October 2011 and on the 2012 New Year’s 
Day (Sunday) was well above the levels seen for weekends in most of the months (Figure 2A). This is 
also observed for another sampling day which was Sunday on the first weekend of May 2012. 
It is noteworthy that the overall patterns of cocaine consumption estimated from cocaine itself and 
benzoylecgonine were very similar, except for a spike in cocaine consumption estimated from 
cocaine itself in one Thursday sample in February 2012 and one Tuesday sample in May 2012 (Figure 
S6A of the Supporting Information). This suggests that there may have been direct release of cocaine 
into the wastewater system on these 2 days. Environmental inputs of cocaine can arise from, for 
example, disposal of cocaine, which provides amounts of cocaine in sewage systems well above 
those from human consumption and results in overestimation of cocaine consumption using 
wastewater samples.e.g.(6, 26) This can also potentially explain the observed difference (an average 
relative difference of 30%) between two estimates in this study (higher consumption when using 
cocaine itself rather than benzoylecgonine) and also slightly higher cocaine/benzoylecgonine ratio in 
the wastewater samples (an average of 0.34) than that in human pharmacokinetic data (0.21 from 
7.5%/35%; see Table S5 of the Supporting Information). Variations in metabolism among individuals 
and mode of administration can also lead to changes in excretion profiles of cocaine, and therefore 
affect the difference in the cocaine/benzoylecgonine ratio between the population in the studied 
catchment and that in pharmacokinetic studies; see, e.g., refs 32 and 33. As noted 
elsewhere,(34) the use of such a dual tracer approach (i.e., both parent drugs and metabolites) gives 
additional confidence in the results and may serve as a quality-control check providing information 
about potential breakdown/transformation of the compounds in the sewers (i.e., higher estimate 
from metabolites) or releases of unconsumed drugs (i.e., higher estimates using the parent 
compound). 
3.4.2Methamphetamine 
As the primarily excreted metabolite, methamphetamine itself was chosen to back-estimate 
methamphetamine consumption. The average yearly consumption (25–75 percentile; median) of 
methamphetamine was estimated at 440 (mg/day)/(1000 people) (312–549; 391).This is equivalent 
to approximately 14 (doses/day)/(1000 people), assuming that a reference dose of 
methamphetamine of 30.5 mg.(25) The use of methamphetamine appeared more prevalent than 
that of cocaine in the catchment, and the variation in methamphetamine consumption (38%) was 
smaller than that of cocaine consumption over the whole monitoring period (Table S7 of 
the Supporting Information). 
The yearly consumption pattern of methamphetamine (Figure S7A and Table S6 of theSupporting 
Information) was similar to that of cocaine (Figure 2A). Most epidemiological data in relation to 
methamphetamine are only compiled in annual aggregates but are generally in keeping with these 
trends: police seizures increased during 2011/-12 in both number and weight, as did the number of 
clandestine laboratories identified;(17) self-reported frequency of use among club drug consumers 
increased and so did the number of calls made about methamphetamine to information lines and 
hospital admissions.(30, 31) Analysis of police seizures demonstrated steady increases in purity over 
the first three-quarters of the 2011/12 period.(17) 
There was higher consumption of methamphetamine on the weekends (average, 523 
(mg/day)/(1000 people)) than the weekdays (406 (mg/day)/(1000 people)) throughout the year 
(Figure 2B) (p < 10–4); the average difference was only about 1.3 times which is less than that for 
cocaine consumption. A few days of elevated methamphetamine consumption were captured 
around specific events in the catchment (Figure S7A of the Supporting Information). 
As for cocaine consumption, we also analyzed amphetamine as another drug residue for the 
estimation of methamphetamine consumption. Both amphetamine and methamphetamine itself 
estimated a similar pattern of methamphetamine consumption (an average relative difference of 
17%) over the monitoring period (Figure S6B of the Supporting Information). The consistency of 
estimating methamphetamine consumption from both amphetamine and methamphetamine itself 
supports other evidence that illicit use of amphetamine is negligible in Australia;(17) hence, 
amphetamine measured in the samples was primarily from the metabolism of methamphetamine 
consumption. 
3.4.3MDMA 
For MDMA, only one excreted residue can be analytically identified with confidence; thus, 
estimating MDMA consumption relies solely on MDMA itself as described in the 
literature.e.g.(35)The average consumption (25–75 percentile; median) of MDMA was estimated at 
about 229 (mg/day)/(1000 people) (75–277; 145) over the year. This is equivalent to an average of 
three doses a day per 1000 people, assuming a reference dose of 80.5 mg.(25) Two discrete rising 
consumption periods of MDMA were observed: June 2011–January 2012 and February–May 2012 
(Figure S7B and Table S6 of the Supporting Information). Epidemiological indicators of MDMA 
consumption increased in this period, with self-reported frequency of use among club drug 
consumers increasing along with perceived purity.(30, 31) Analysis of police seizures demonstrated 
that purity increased between the third and fourth quarters of 2011, declining in the first quarter of 
2012 and increasing in the second quarter of 2012.(17) While these purity data are based on a 
restricted number of seizures, the general pattern is consistent with the fluctuations detected in the 
wastewater samples in this study (Figure S7B of the Supporting Information). 
A strong weekend effect was observed on MDMA consumption similar to that for cocaine. It was 
approximately two times higher on weekends (yearly average, 347 (mg/day)/(1000 people); Table S6 
of the Supporting Information) than on weekdays (181 (mg/day)/(1000 people)) (p < 10–4). This 
pattern of use is consistent with trends reported in consumer studies.(30, 31, 36) A few spikes were 
identified in the quantities of MDMA consumed over the study period (Figure S7B of the Supporting 
Information). Some of these spikes coincided with major events in the catchment, confirming 
previous findings of links between MDMA use and musical entertainment events.(37, 38) 
3.5Overall Methodological Uncertainty 
Three different evaluations were performed to calculate the total uncertainty (Utot) of PNDC 
(Table 1). First, the components UC, US, UF, and UE are typically considered for Utot. Often, UPis 
unfortunately excluded because it is unknown and obtaining a realistic, independent, and site-
specific estimate is difficult. Applying Monte Carlo simulation, the average Utot was estimated at 
approximately 22% for the three illicit drugs over the monitoring period (see Table 1 for details and 
range), in which UF is the most dominant uncertainty component. This estimate was similar to our 
previous finding for this urban catchment.(8) Second, when considering a conservative value of 50% 
(range 7–55%, according to Castiglioni et al.)(12) for UP—analogue to the uncertain knowledge of 
population (wide prior) used for Bayesian updating in the population estimation model(11)—Utot(de 
jure) would be approximately 57% for the three illicit drugs, in which UP becomes the dominating 
uncertainty factor. Third, as mentioned previously, the dailyde facto population is estimated from 
chemical mass loads which are calculated with the same daily flow data as the daily illicit drug loads. 
Thus, UF affects both daily de facto population estimates and illicit drug loads in the same way and 
cancels out when calculating PNDC. For calculating de facto-PNDC, the Utot(de facto) is, therefore, 
based on US, UC, UE, and UP. For UP, the multisubstance model estimated an average of 3.5% over 
the monitoring period (posterior of population estimation(11)). The average Utot(de facto) is then 
estimated at approximately 10% for all compounds (Table 1). 
Table 1. Evaluation of the Total Methodological Uncertainty (RSD %) for Estimating Illicit Drug 
Consumption between Normalization to the de jurePopulation and the Estimated de 
facto Population Using Monte Carlo Simulation 
  cocaine methamphetamine MDMA 
  UPignored UPconsidered UPignored UPconsidered UPignored UPconsidered 
with de jure populations             
US 5.0 5.0 5.0 5.0 5.0 5.0 
UC 7.1 7.1 5.1 5.1 9.8 9.8 
UF 20 20 20 20 20 20 
UE 1.9 1.9 0.82 0.82 2.3 2.3 
UP n.a.a 50 n.a. 50 n.a. 50 
Utot 22 (22–23) 57 (54–61) 21 (21–22) 56 (53–62) 23 (23–24) 57 (55–62) 
with de facto populations            
US   5.0   5.0   5.0 
UC   7.1   5.1   9.8 
  cocaine methamphetamine MDMA 
  UPignored UPconsidered UPignored UPconsidered UPignored UPconsidered 
UF   –   –   – 
UE   1.9   0.82   2.3 
UP   3.5 (2.1–9.7)   3.5 (2.1–9.7)   3.5 (2.1–9.7) 
Utot   9.6 (9.1–13)   8.0 (7.5–12)   12 (11–15) 
a 
n.a., not applicable; −, uncertainty of flow cancels out for population-normalized drug loads since de 
facto population estimate is affected in the same way as illicit drug loads. See Lai et al.(8) for the 
details of quantifying the uncertainty components. 
There was a distinctive difference among a typical Utot, Utot(de jure), and Utot(de facto) for the 
three illicit drugs over the monitoring period (Figure 2 and Figures S8 and S9 of the Supporting 
Information). The levels of Utot for estimating cocaine consumption was clearly diminished in a 
decreasing order as follows: Utot(de jure) (Figure 2C) > a typical Utot (Figure 2B) > Utot(de facto) 
(Figure 2A). The same holds true for estimating methamphetamine and MDMA consumption 
(Figures S8 and S9 of the Supporting Information). Our data clearly revealed a substantial reduction 
in the Utot when a day-specific de facto population was estimated from chemicals in the same 
sample as used to measure illicit drug residues. A European-wide study estimated about 26% (a 
typical Utot) as the uncertainty of estimating cocaine consumption.(12) A similar level was also 
estimated in our study, but our data reflected a much lower level when using the daily estimated de 
facto populations. 
This study showed an objective quantification of the total methodological uncertainty and achieved 
a substantial reduction thereof. In our case, the total uncertainty of the de facto-PNDC was reduced 
by a factor of 2 because of (i) eliminating the uncertainty of flow measurements and (ii) performing a 
unique assessment of uncertainty related to the population size. Whether or not the effort to reduce 
the total methodological uncertainty from about 20% to 10% for a daily value is justified, there 
remains an open discussion and it depends on the specific application and setting. However, it 
appears that avoiding a systematic over- or underestimation of PNDC—which normally remains 
undiscovered—is highly desirable, particularly when comparing consumption data across different 
locations. With a dataset that covers a much shorter duration and does not cover consecutive days, 
we could have not derived these findings and substantiated our conclusions. This also holds true for 
the identification of monitoring days that require more attention for interpretation. In combination 
with previously summarized long-term studies,(23) our study offers guidance to optimize future 
monitoring campaigns where financial or logistic reasons limit the numbers of sampling days for 
evaluation. A remaining challenge is to interpret an estimated population of, e.g., 100,000 people, as 
different settings could have led to this result: (1) 100,000 people all being present in a catchment 
over 24 h and having used the toilet an average of five times; or (2) 500,000 people in transit 
through the catchment area using the toilet an average of only once in the day, as an extreme 
opposite. Both situations would result in approximately 500,000 toilet flushes. 
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 Figure 1. (A) Estimated daily de facto populations from the wastewater samples over the monitoring 
period (orange solid line, the de jure population of 211,340 persons). (B) Percentage differences 
between the daily de facto population and the de jure population (i.e., differences of the two 
estimates divided by the de jure population). (C) Deviations (percentage differences) of per capita 
consumption rates between normalization to the estimated de facto population and the de 
jure population. This panel is different from that of panel B due to the fact that the population 
estimate influences the population-normalized estimates by (de jure/de facto – 1) (see 
section 3.3 for details). Black bars along the X-axis = missing date (see Table S1 of the Supporting 
Information); triangles along the X-axis = days with special dates/events. Figure S1 of the Supporting 
Information shows a direct comparison of data between the weekends and weekdays for panel A 
(see Table S6 of the Supporting Information for the numerical data of the monthly average and the 
average over the entire monitoring period). 
  
Figure 2. Estiamted population-normalized consumption for cocaine considering different population 
estimates and uncertainty components: (A) de factopopulation normalized consumption 
with Utot(de facto) = US + UC + UE + UP(de facto); (B) de jure population normalized consumption 
with a typical Utot = US +UC + UE + UF; (C) de jure population normalized consumption with Utot(de 
jure) =US + UC + UE + UF + UP(de jure). Black bars along the X-axis = missing dates (see Table S1 of 
the Supporting Information); triangles along the X-axis = days with special dates/events. Figure S1 of 
the Supporting Information shows a direct comparison of data between the weekends and 
weekdays for A (see Table S6 of the Supporting Information for the numerical data of the monthly 
average and the average over the entire monitoring period). 
 
 
